Table 5: Distribution of major SCCmec and pulsotypes among MRSA isolates according to antibiotic resistant phenotype.
Antibiotic Resistant Phenotypes |
No. (%) |
Major SCCmec Types No. (%) |
Major PulsotypesNo. (%) |
I |
II |
III |
IV |
N |
1 |
6 |
12 |
15 |
31 |
CefoxitinC |
36(100) |
9(25) |
10(27) |
7(19.4) |
6(16.6) |
4(11.1) |
4(12.1) |
6(18.1) |
1(3) |
6(18.1) |
2(6) |
Gentamicin |
30(83.3) |
9(25) |
7(19.4) |
7(19.4) |
5(13.8) |
2(5.5) |
3(9) |
6(18.1) |
1(3) |
5(15.1) |
1(3) |
Erythromycin |
30(83.3) |
8(22.2) |
7(19.4) |
6(16.6) |
5(13.8) |
4(11.1) |
3(9) |
6(18.1) |
0(0) |
5(15.1) |
0(0) |
Doxycycline |
12(33.3) |
3(8.3) |
2(5.5) |
4(11.1) |
1(2.7) |
2(5.5) |
1(3) |
2(6) |
0(0) |
3(9) |
0(0) |
Minocycline |
5(13.8) |
3(8.3) |
1(2.7) |
1(2.7) |
0(0) |
0(0) |
1(3) |
2(6) |
0(0) |
2(6) |
0(0) |
Ciprofloxacin |
11(30.5) |
5(13.8) |
3(8.3) |
2(5.5) |
1(2.7) |
0(0) |
3(9) |
2(6) |
1(3) |
1(3) |
0(0) |
Clindamycin |
19(52.7) |
5(13.8) |
3(8.3) |
6(16.6) |
3(8.3) |
2(5.5) |
3(9) |
3(9) |
1(3) |
2(6) |
1(3) |
Trimethoprim |
14(38.8) |
3(8.3) |
2(5.5) |
3(8.3) |
4(11.1) |
2(5.5) |
2(6) |
2(6) |
1(3) |
2(6) |
1(3) |
Rifampin |
13(36.1) |
6(16.6) |
2(5.5) |
4(11.1) |
0(0) |
1(2.7) |
1(3) |
2(6) |
1(3) |
1(3) |
1(3) |
Quinupristindalfopristin |
1(2.7) |
0(0) |
0() |
0(0) |
0(0) |
1(2.7) |
0(0) |
0(0) |
0(0) |
1(3) |
0(0) |
Linezolid |
1(2.7) |
0(0) |
0() |
1(2.7) |
0(0) |
0(0) |
0(0) |
0(0) |
0(0) |
0(0) |
1(3) |